Mr. Bin Sun is currently the Managing Director and Member of Investment Decision Committee of EverBright Holding Healthcare Fund. Mr. Sun has more than 16 years’ experience in healthcare industry and investment in US and China. Previously, Mr. Sun was the Executive Director of Direct Investment Department of CICC, participated in fund raising of a $500 million CICC PE Growth Fund, and a 5 billion CICC RMB Fund. He led and completed a 190 million RMB MBO investment from CICC Jiatai Fund to Shenzhen SonoScape, and a $30 million investment from CICC Growth Fund to China Diagnostics. Prior to that, Mr. Sun was the Vice President for Alliance Bernsterin (one of the largest investment institution in the United States), responsible for theme trend oriented investment research to listed companies and AB Venture Capital PE investment to starting-up high-tech companies. Prior to that, Mr. Sun worked in the world’s leading biopharmaceutical companies Amgen and Biogen ldec, engaged in new drug development, business development and mergers and acquisitions.
Mr. Sun received his MBA from New York University, MS in Pharmaceutical Sciences from University of Michigan, MS in Chemistry from University of Kentucky, and a BS from Peking University.